Pixabay
According to a recent Fox News article, the FDA has approved the first chikungunya vaccine, called Ixchiq, developed by Valneva. The vaccine is intended for people 18 and older who are at risk of exposure to the chikungunya virus, which is transmitted via mosquitos. Chikungunya is categorized as an "emerging global health threat," with at least five million cases reported in the past 15 years. The virus can cause severe and prolonged health issues, particularly in older adults and those with underlying medical conditions.
